← Back to home

CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE

Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE explained in plain language.

Never miss a new study

Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE trials appear

Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a common vaccine help the immune system fight cancer?

Disease control Ongoing

This study is testing if giving a low-dose cancer drug (lenalidomide) along with a standard pneumonia vaccine can help the body's immune system better recognize and attack early-stage chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It enrolled 49 adults wi…

Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE

Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA WITH UNMUTATED IMMUNOGLOBULIN HEAVY CHAIN VARIABLE-REGION GENE trials appear

Can a common vaccine help the immune system fight cancer?